DexCom, Inc. (DXCM)
86.04
-1.67
(-1.90%)
USD |
NASDAQ |
Oct 16, 16:00
85.90
-0.14
(-0.16%)
After-Hours: 20:00
DexCom Cash from Investing (Quarterly) : 329.80M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 329.80M |
| March 31, 2026 | -298.50M |
| December 31, 2025 | 306.60M |
| September 30, 2025 | 192.80M |
| June 30, 2025 | -63.60M |
| March 31, 2025 | 100.20M |
| December 31, 2024 | -303.70M |
| September 30, 2024 | 210.30M |
| June 30, 2024 | -188.90M |
| March 31, 2024 | 74.80M |
| December 31, 2023 | 414.90M |
| September 30, 2023 | -179.50M |
| June 30, 2023 | -555.90M |
| March 31, 2023 | -186.70M |
| December 31, 2022 | -194.10M |
| September 30, 2022 | 229.30M |
| June 30, 2022 | -144.90M |
| March 31, 2022 | -411.80M |
| December 31, 2021 | -496.10M |
| September 30, 2021 | 29.00M |
| June 30, 2021 | 363.20M |
| March 31, 2021 | -112.20M |
| December 31, 2020 | -24.00M |
| September 30, 2020 | -9.30M |
| June 30, 2020 | -1.115B |
| Date | Value |
|---|---|
| March 31, 2020 | 130.60M |
| December 31, 2019 | -94.30M |
| September 30, 2019 | -412.80M |
| June 30, 2019 | -639.40M |
| March 31, 2019 | 131.30M |
| December 31, 2018 | 30.90M |
| September 30, 2018 | 4.60M |
| June 30, 2018 | -159.90M |
| March 31, 2018 | -15.40M |
| December 31, 2017 | -1.10M |
| September 30, 2017 | -36.60M |
| June 30, 2017 | -85.30M |
| March 31, 2017 | -21.40M |
| December 31, 2016 | -17.30M |
| September 30, 2016 | -17.80M |
| June 30, 2016 | -9.60M |
| March 31, 2016 | -11.20M |
| December 31, 2015 | -12.70M |
| September 30, 2015 | -5.70M |
| June 30, 2015 | -7.20M |
| March 31, 2015 | -25.90M |
| December 31, 2014 | -4.70M |
| September 30, 2014 | -3.80M |
| June 30, 2014 | -4.00M |
| March 31, 2014 | -4.30M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -673.00M |
| Baxter International, Inc. | -117.00M |
| Stryker Corp. | -639.00M |
| Becton, Dickinson & Co. | -228.00M |
| Insulet Corp. | -37.40M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 269.20M |
| Cash from Financing (Quarterly) | -607.30M |
| Free Cash Flow | 1.405B |
| Free Cash Flow Per Share (Quarterly) | 0.473 |
| Free Cash Flow to Equity (Quarterly) | 170.90M |
| Free Cash Flow to Firm (Quarterly) | 186.85M |
| Free Cash Flow Yield | 4.11% |